Viking aims to enter a market that may be worth $100 billion in a few years. Patients and investors are excited about this class of drug thanks to impressive results in clinical trials and in the real ...

Winning a prestigious tournament can be the highlight of any captain’s career, but to win one three years in a row represents an incredible feat, especially when the competition is tougher than ever.

Viking Therapeutics(NASDAQ: VKTX) shares soared more than 120% in one trading session last month as investors bet on its ability to win in the billion-dollar weight-loss drug market -- or attract a ...